Anti-Angiogenic Properties of Ginsenoside Rg3

Ginsenoside Rg3 (Rg3) is a member of the ginsenoside family of chemicals extracted from <i>Panax ginseng</i>. Like other ginsenosides, Rg3 has two epimers: 20(S)-ginsenoside Rg3 (SRg3) and 20(R)-ginsenoside Rg3 (RRg3). Rg3 is an intriguing molecule due to its anti-cancer properties. One...

Full description

Bibliographic Details
Main Authors: Maryam Nakhjavani, Eric Smith, Amanda R. Townsend, Timothy J. Price, Jennifer E. Hardingham
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/21/4905
id doaj-71602661ddfe407aa03f9f9d3bdf5000
record_format Article
spelling doaj-71602661ddfe407aa03f9f9d3bdf50002020-11-25T03:32:45ZengMDPI AGMolecules1420-30492020-10-01254905490510.3390/molecules25214905Anti-Angiogenic Properties of Ginsenoside Rg3Maryam Nakhjavani0Eric Smith1Amanda R. Townsend2Timothy J. Price3Jennifer E. Hardingham4Molecular Oncology, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, SA 5011, AustraliaMolecular Oncology, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, SA 5011, AustraliaAdelaide Medical School, University of Adelaide, Adelaide, SA 5005, AustraliaAdelaide Medical School, University of Adelaide, Adelaide, SA 5005, AustraliaMolecular Oncology, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, SA 5011, AustraliaGinsenoside Rg3 (Rg3) is a member of the ginsenoside family of chemicals extracted from <i>Panax ginseng</i>. Like other ginsenosides, Rg3 has two epimers: 20(S)-ginsenoside Rg3 (SRg3) and 20(R)-ginsenoside Rg3 (RRg3). Rg3 is an intriguing molecule due to its anti-cancer properties. One facet of the anti-cancer properties of Rg3 is the anti-angiogenic action. This review describes the controversies on the effects and effective dose range of Rg3, summarizes the evidence on the efficacy of Rg3 on angiogenesis, and raises the possibility that Rg3 is a prodrug.https://www.mdpi.com/1420-3049/25/21/4905ginsenoside Rg320(S)-ginsenoside Rg320(R)-ginsenoside Rg3angiogenesisepimer
collection DOAJ
language English
format Article
sources DOAJ
author Maryam Nakhjavani
Eric Smith
Amanda R. Townsend
Timothy J. Price
Jennifer E. Hardingham
spellingShingle Maryam Nakhjavani
Eric Smith
Amanda R. Townsend
Timothy J. Price
Jennifer E. Hardingham
Anti-Angiogenic Properties of Ginsenoside Rg3
Molecules
ginsenoside Rg3
20(S)-ginsenoside Rg3
20(R)-ginsenoside Rg3
angiogenesis
epimer
author_facet Maryam Nakhjavani
Eric Smith
Amanda R. Townsend
Timothy J. Price
Jennifer E. Hardingham
author_sort Maryam Nakhjavani
title Anti-Angiogenic Properties of Ginsenoside Rg3
title_short Anti-Angiogenic Properties of Ginsenoside Rg3
title_full Anti-Angiogenic Properties of Ginsenoside Rg3
title_fullStr Anti-Angiogenic Properties of Ginsenoside Rg3
title_full_unstemmed Anti-Angiogenic Properties of Ginsenoside Rg3
title_sort anti-angiogenic properties of ginsenoside rg3
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2020-10-01
description Ginsenoside Rg3 (Rg3) is a member of the ginsenoside family of chemicals extracted from <i>Panax ginseng</i>. Like other ginsenosides, Rg3 has two epimers: 20(S)-ginsenoside Rg3 (SRg3) and 20(R)-ginsenoside Rg3 (RRg3). Rg3 is an intriguing molecule due to its anti-cancer properties. One facet of the anti-cancer properties of Rg3 is the anti-angiogenic action. This review describes the controversies on the effects and effective dose range of Rg3, summarizes the evidence on the efficacy of Rg3 on angiogenesis, and raises the possibility that Rg3 is a prodrug.
topic ginsenoside Rg3
20(S)-ginsenoside Rg3
20(R)-ginsenoside Rg3
angiogenesis
epimer
url https://www.mdpi.com/1420-3049/25/21/4905
work_keys_str_mv AT maryamnakhjavani antiangiogenicpropertiesofginsenosiderg3
AT ericsmith antiangiogenicpropertiesofginsenosiderg3
AT amandartownsend antiangiogenicpropertiesofginsenosiderg3
AT timothyjprice antiangiogenicpropertiesofginsenosiderg3
AT jenniferehardingham antiangiogenicpropertiesofginsenosiderg3
_version_ 1724566201025167360